ACME Laboratories (DHA:ACMELAB) Long-Term Capital Lease Obligation : BDT50 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Long-Term Capital Lease Obligation?

ACME Laboratories's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was BDT50 Mil.

ACME Laboratories's quarterly Long-Term Capital Lease Obligation declined from Jun. 2024 (BDT45 Mil) to Sep. 2024 (BDT42 Mil) but then increased from Sep. 2024 (BDT42 Mil) to Dec. 2024 (BDT50 Mil).

ACME Laboratories's annual Long-Term Capital Lease Obligation declined from Jun. 2022 (BDT73 Mil) to Jun. 2023 (BDT62 Mil) and declined from Jun. 2023 (BDT62 Mil) to Jun. 2024 (BDT45 Mil).

ACME Laboratories Long-Term Capital Lease Obligation Historical Data

The historical data trend for ACME Laboratories's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Long-Term Capital Lease Obligation Chart

ACME Laboratories Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

66.78

62.89

73.20

62.29

44.87

ACME Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	49.48	44.87	41.98	49.82

ACME Laboratories (DHA:ACMELAB) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

ACME Laboratories Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

ACME Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207

Website

https://www.acmeglobal.com

ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.

ACME Laboratories Headlines

No Headlines